US2005282215A1PendingUtilityA1

Isolated cytokine receptor LICR-2

Assignee: RENAULD JEAN-CHRISTOPHEPriority: Dec 21, 2001Filed: Jul 19, 2005Published: Dec 22, 2005

Est. expiryDec 21, 2021(expired)· nominal 20-yr term from priority

Inventors:Jean-Christophe Renauld Helmut Fickenscher Laure Dumoutier Simon Hor

C07K 14/715A61K 38/00

PatentIndex Score

Cited by

References

Claims

Abstract

The invention relates to new members of the Class II cytokine receptor family, such as LICR-2. The new member binds to AK155, and mediates STAT activation.

Claims

exact text as granted — not AI-modified

1 - 37 . (canceled)  
     
     
         38 . Isolated antibody which specifically binds to an isolated protein encoded by an isolated nucleic acid molecule which encodes a cytokine receptor, wherein the complementary nucleotide sequence of said isolated nucleic acid molecule, hybridizes, under stringent conditions, to SEQ ID NO: 7 or SEQ ID NO: 9.  
     
     
         39 . The antibody of  claim 38 , wherein said antibody is monoclonal antibody.  
     
     
         40 . Hybridoma cell line which produces the monoclonal antibody of  claim 39.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.